These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
68 related items for PubMed ID: 2830536
21. Evaluation of principal cannabinoids in airborne particulates. Balducci C, Nervegna G, Cecinato A. Anal Chim Acta; 2009 May 08; 641(1-2):89-94. PubMed ID: 19393371 [Abstract] [Full Text] [Related]
22. Effect of cannabinoids on spermatogenesis in vivo: a cytological study. Zimmerman AM, Murer-Orlando ML, Richer CL. Cytobios; 1986 May 08; 45(180):7-15. PubMed ID: 3011361 [Abstract] [Full Text] [Related]
23. Interaction between naltrexone and oral THC in heavy marijuana smokers. Haney M, Bisaga A, Foltin RW. Psychopharmacology (Berl); 2003 Feb 08; 166(1):77-85. PubMed ID: 12491025 [Abstract] [Full Text] [Related]
24. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits. Mannila J, Järvinen T, Järvinen K, Tarvainen M, Jarho P. Eur J Pharm Sci; 2005 Sep 08; 26(1):71-7. PubMed ID: 15955678 [Abstract] [Full Text] [Related]
25. Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997. ElSohly MA, Ross SA, Mehmedic Z, Arafat R, Yi B, Banahan BF. J Forensic Sci; 2000 Jan 08; 45(1):24-30. PubMed ID: 10641915 [Abstract] [Full Text] [Related]
26. [Passive inhalation of cannabis smoke--is it detectable?]. Westin AA, Slørdal L. Tidsskr Nor Laegeforen; 2009 Jan 15; 129(2):109-13. PubMed ID: 19151803 [Abstract] [Full Text] [Related]
27. Double-blind assessment of buprenorphine withdrawal in opiate-addicts. Camí J, Guerra D, Ugena B, Segura J, de la Torré R. NIDA Res Monogr; 1990 Jan 15; 105():345. PubMed ID: 1652076 [No Abstract] [Full Text] [Related]
29. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana. Zhu HJ, Wang JS, Markowitz JS, Donovan JL, Gibson BB, Gefroh HA, Devane CL. J Pharmacol Exp Ther; 2006 May 15; 317(2):850-7. PubMed ID: 16439618 [Abstract] [Full Text] [Related]
30. Neuroprotective antioxidants from marijuana. Hampson AJ, Grimaldi M, Lolic M, Wink D, Rosenthal R, Axelrod J. Ann N Y Acad Sci; 2000 May 15; 899():274-82. PubMed ID: 10863546 [Abstract] [Full Text] [Related]
31. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices. Reichman M, Nen W, Hokin LE. Mol Pharmacol; 1988 Dec 15; 34(6):823-8. PubMed ID: 2849049 [Abstract] [Full Text] [Related]
36. Anticonvulsant effect of cannabidiol. Ames FR, Cridland S. S Afr Med J; 1986 Jan 04; 69(1):14. PubMed ID: 3941934 [No Abstract] [Full Text] [Related]
37. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK. Clin Pharmacol Ther; 1980 Sep 04; 28(3):409-16. PubMed ID: 6250760 [Abstract] [Full Text] [Related]
39. Cannabis: pharmacology and toxicology in animals and humans. Adams IB, Martin BR. Addiction; 1996 Nov 04; 91(11):1585-614. PubMed ID: 8972919 [Abstract] [Full Text] [Related]
40. Oral CBD-rich hemp extract modulates sterile inflammation in female and male rats. Hopkins S, Kelley T, Roller R, Thompson RS, Colagiovanni DB, Chupka K, Fleshner M. Front Physiol; 2023 Nov 04; 14():1112906. PubMed ID: 37275221 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]